PGV-001

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePGV-001
Drug Alias Namepersonalized peptide vaccine 001multi-peptide therapeutic vaccine 001personalized peptides plus Poly-ICLC vaccine 001PGV-001
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll like receptor 3 agonists
TargetsToll like receptor 3
Therapy Area/IndicationsUrologic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIcahn School Of Medicine At Mount SinaiGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesIcahn School Of Medicine At Mount SinaiGenentech Inc
Inactive CompaniesN/A
Active IndicationsUrologic NeoplasmsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A